COX-2: a protein with an active role in gynecological cancers
Authors:
- Adnan MunkarahAMAdnan Munkarah
- Rouba Ali-FehmiRARouba Ali-Fehmi
- 1 February 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 17 (1) , 49-53
Abstract
Emerging data suggest that COX-2 is involved at various steps of the process of malignant transformation and tumor progression. The current article reviews the latest data linking COX-2 with the various gynecological cancers. COX-2 overexpression has been reported in most gynecological neoplasms, including breast, cervix, endometrial and epithelial ovarian cancers. COX-2 expression promotes tumor cell proliferation, reduces apoptosis and induces angiogenesis. As a result, tumors expressing COX-2 are reported to exhibit a more aggressive phenotype and clinical behavior. Women whose tumors over-express COX-2 tend to have a lower response to standard therapy and shorter survival times. In-vitro studies have shown that COX-2 inhibitors can inhibit tumor cell growth and reduce angiogenesis. On the basis of the current data and the clinical availability of safe inhibitors, COX-2 is a perfect target for cancer prevention and therapy. A number of trials are investigating the benefits of combining COX-2 inhibitors with existing treatment modalities in the management of breast, ovarian and cervical cancers. In addition, large prevention trials are in the planning stage.Keywords
This publication has 29 references indexed in Scilit:
- Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer RiskJAMA, 2004
- Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast CancerAnnals of Surgical Oncology, 2004
- Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Cyclooxygenase‐2 expression: a potential prognostic and predictive marker for high‐grade ductal carcinoma in situ of the breastHistopathology, 2004
- Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breastCancer Causes & Control, 2003
- Medication use and risk of ovarian carcinoma: A prospective studyInternational Journal of Cancer, 2003
- Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyBritish Journal of Cancer, 2003
- Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.Journal of Clinical Investigation, 1994
- Towards a better aspirinNature, 1994
- The Role of Cytokines in the Production of Prostacyclin and Thromboxane in Human Mononuclear CellsImmunological Investigations, 1994